What's breaking now, across thousands of outlets.
(MedPage Today) -- Three women experienced neurological symptoms after injections of botulinum toxin at a medical spa in Colorado, which turned out to be an unapproved product, public health officials said. All three had injections in the upper...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.
The Ghana Atomic Energy Commission (GAEC) has warned Ghanaians about the risk of lung cancer from exposure to radon gas, urging households to improve ventilation by keeping windows open to prevent the…
Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.
First-of-its-kind study launches ahead of World Mental Health Day providing free coaching to first responders in partnership with Workplace Safety and Insurance Board of Ontario TORONTO — BetterUp…
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.
KUALA LUMPUR: Guardian Malaysia says the 2027 Budget's higher healthcare tax relief will help ease medical costs for households and make essential healthcare more affordable.
